WO2022071463A1 - 粘性組成物 - Google Patents
粘性組成物 Download PDFInfo
- Publication number
- WO2022071463A1 WO2022071463A1 PCT/JP2021/036041 JP2021036041W WO2022071463A1 WO 2022071463 A1 WO2022071463 A1 WO 2022071463A1 JP 2021036041 W JP2021036041 W JP 2021036041W WO 2022071463 A1 WO2022071463 A1 WO 2022071463A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- cellulose
- viscous composition
- salt
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 100
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims abstract description 77
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims abstract description 75
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims abstract description 75
- 229920002678 cellulose Polymers 0.000 claims abstract description 51
- 239000001913 cellulose Substances 0.000 claims abstract description 51
- 150000003839 salts Chemical class 0.000 claims abstract description 50
- 239000002159 nanocrystal Substances 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000003431 cross linking reagent Substances 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 17
- 238000002834 transmittance Methods 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- -1 dialdehyde compound Chemical class 0.000 claims description 15
- 238000005259 measurement Methods 0.000 claims description 14
- 238000003860 storage Methods 0.000 claims description 11
- 239000006185 dispersion Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229920001046 Nanocellulose Polymers 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 229910019142 PO4 Inorganic materials 0.000 description 7
- 239000010452 phosphate Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- 230000001771 impaired effect Effects 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002028 Biomass Substances 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000005227 gel permeation chromatography Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- 210000001724 microfibril Anatomy 0.000 description 4
- 239000002121 nanofiber Substances 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940015043 glyoxal Drugs 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical class OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical class CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- UWHCZFSSKUSDNV-UHFFFAOYSA-N 3-(aziridin-1-yl)propanoic acid;2-ethyl-2-(hydroxymethyl)propane-1,3-diol Chemical compound OC(=O)CCN1CC1.OC(=O)CCN1CC1.OC(=O)CCN1CC1.CCC(CO)(CO)CO UWHCZFSSKUSDNV-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical class CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical class C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical class N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- JXTHNDFMNIQAHM-UHFFFAOYSA-M dichloroacetate Chemical compound [O-]C(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-M 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical class OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940114119 gentisate Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940099584 lactobionate Drugs 0.000 description 1
- JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- YVOQADGLLJCMOE-UHFFFAOYSA-N n-[6-(aziridine-1-carbonylamino)hexyl]aziridine-1-carboxamide Chemical compound C1CN1C(=O)NCCCCCCNC(=O)N1CC1 YVOQADGLLJCMOE-UHFFFAOYSA-N 0.000 description 1
- XTEGVFVZDVNBPF-UHFFFAOYSA-L naphthalene-1,5-disulfonate(2-) Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1S([O-])(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-L 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- LNDCCSBWZAQAAW-UHFFFAOYSA-M sodium hydrogen sulfate sulfuric acid Chemical compound [Na+].OS(O)(=O)=O.OS([O-])(=O)=O LNDCCSBWZAQAAW-UHFFFAOYSA-M 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
Definitions
- the present disclosure relates to a viscous composition and the like, and more particularly to a viscous composition containing cellulose nanocrystals.
- the contents of all documents described in this specification are incorporated herein by reference.
- Polymer thickeners are widely used for preparing viscous compositions in various fields, such as cosmetics and food fields.
- hydroxyethyl cellulose HEC
- HEC hydroxyethyl cellulose
- the present inventors have studied to find a novel means for providing a viscous composition containing hydroxyethyl cellulose and a salt but having excellent viscosity and stability.
- the present inventors have prepared a viscous composition obtained by mixing nanocellulose, particularly cellulose nanocrystal, with hydroxyethyl cellulose and dissolving it in water, which is a stable composition in which the viscosity does not easily decrease even when a salt is added. I found something and repeated further studies.
- Item 1 Contains cellulose nanocrystals, hydroxyethyl cellulose, water-soluble salts, as well as water, The viscosity at 25 ° C. is 10,000 mPa ⁇ s or more (preferably 10,000 to 20,000 mPa ⁇ s). Viscous composition.
- Item 2. Item 2. The viscous composition according to Item 1, wherein the hydroxyethyl cellulose is hydroxyethyl cellulose crosslinked with a cross-linking agent.
- Hydroxyethyl cellulose crosslinked with the crosslinking agent A crosslinked hydroxyethyl cellulose containing 0.35% by mass or more (preferably 0.35 to 2% by mass) of a crosslinking agent.
- Item 4. Item 2. The viscous composition according to Item 2 or 3, wherein the cross-linking agent is a dialdehyde compound.
- Item 5. Item 2. The viscous composition according to any one of Items 1 to 4, wherein the content of the water-soluble salt is 0.1% by mass or more (preferably 1 to 10% by mass).
- the magnitude relationship between the storage elastic modulus G'and the loss elastic modulus G'' obtained by the frequency dispersion measurement is the storage elastic modulus G'> the loss elastic modulus G'> in the entire frequency range of 0.1 rad / s to 100 rad / s.
- Item 3. The viscous composition according to any one of Items 1 to 6.
- Item 8. A method for producing a viscous composition, which comprises mixing (1) a mixture of cellulose nanocrystals and hydroxyethyl cellulose with water, and (2) adding a water-soluble salt to the mixture.
- (1) A method for producing a viscous composition for adding a water-soluble salt which comprises mixing a mixture of cellulose nanocrystals and hydroxyethyl cellulose with water.
- Item 8. The method according to Item 8 or 9, further comprising mixing (0) cellulose nanocrystals and hydroxyethyl cellulose before (1).
- a viscous composition containing hydroxyethyl cellulose and a salt but having excellent viscosity and stability is provided.
- the present disclosure preferably includes, but is not limited to, a viscous composition, a method for producing the same, and the like, and the present disclosure includes all disclosed in the present specification and recognized by those skilled in the art.
- the viscous composition included in the present disclosure contains cellulose nanocrystals, hydroxyethyl cellulose, and water.
- the viscous composition included in the present disclosure may be referred to as "the composition of the present disclosure”.
- the compositions of the present disclosure also include viscous compositions containing salts in addition to cellulose nanocrystals, hydroxyethyl cellulose, and water.
- those containing salt may be referred to as “salt-containing compositions of the present disclosure”
- those containing no salt may be referred to as “salt-free compositions of the present disclosure”.
- Cellulose nanocrystal is a kind of nanocellulose.
- examples of nanocellulose made from wood or the like include cellulose nanofibers (CNF) and cellulose nanocrystals (CNC).
- CNF cellulose nanofibers
- CNC cellulose nanocrystals
- nanocellulose having a length of about 5 to 10 ⁇ m or more is often referred to as cellulose nanofiber (CNF)
- CNC cellulose nanocrystal
- the nanocrystalline cellulose described in Patent Document 1 Japanese Patent Laid-Open No. 2012-531478 can be preferably used.
- Cellulose is a natural polymer material that constitutes woody biomass and agricultural biomass together with hemicellulose and lignin. It is a homopolymer of repeating units of glucose linked by ⁇ -1,4-glycosidic bonds. Cellulose is formed linearly by ⁇ -1,4-glycosidic bonds, and they interact strongly with each other through hydrogen bonds. Due to its regular structure and strong hydrogen bonds, the cellulose polymer is highly crystalline and aggregates to form partial structures and microfibrils. Then, the microfibrils aggregate to form cellulosic fibers.
- Nanocellulose is a rod-shaped fibril with a length / diameter ratio of approximately 20-200.
- nanocellulose can be prepared, for example, from chemical pulp of wood fiber or agricultural fiber by removing the amorphous region mainly by acid hydrolysis to produce nano-sized fibril.
- Cellulose nanocrystals can be formed and stabilized in an aqueous suspension by, for example, sonicating the fibrils or passing them through a high shear microfluidizer.
- the second method is mainly physical processing. Bundles of microfibrils, usually tens of nanometers (nm) to several micrometer ( ⁇ m) in diameter, called cellulose microfibrils or microfibrillated cellulose, are produced by using high pressure homogenization and grinding. .. Steps with high intensity sonication have also been used to isolate fibril from natural cellulose fibers. High-intensity ultrasound can generate very strong mechanical vibration forces, which allows the separation of cellulose fibrils from biomass. This method produces microfibrillated cellulose having a diameter of less than about 60 nm, more preferably about 4 nm to about 15 nm, and a length of less than 1000 nm. Microfibrillated cellulose can also be subjected to, for example, further chemical, enzymatic and / or mechanical treatments. The microfibrillated cellulose can also be used as a cellulose nanocrystal.
- the cellulose nanocrystals used in the compositions of the present disclosure are, for example, by removing amorphous regions from pulp by acid hydrolysis, or by physical treatment such as high pressure treatment, pulverization treatment, and ultrasonic treatment. It can be appropriately prepared by treatment (and even by using these in combination).
- the cellulose portion of the cellulose nanocrystal used in the composition of the present disclosure may be a cellulose sulfate (cellulose sulfate).
- a sodium salt is preferable. That is, the cellulose portion of the cellulose nanocrystal used in the composition of the present disclosure may be cellulose sulfate sodium sulfate.
- the composition of the present disclosure can have excellent viscosity and stability even if a salt is contained.
- cellulose nanocrystal indicates a crystal of nano-sized cellulose
- the cellulose may be an unmodified form or a modified form.
- the cellulose modified product for example, cellulose sulfate (particularly sodium cellulose sulfate) is preferably mentioned.
- examples of the CNC include nanocellulose having a thickness of about 1 to 100 nm and a length of about 50 to 500 nm.
- the upper or lower limit of the thickness range (1 to 100 nm) is, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, and so on.
- the thickness range may be 2 to 99 nm.
- the upper limit or the lower limit of the length range (50 to 500 nm) is, for example, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, 300, 310, 320, 330, 340, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, or 490 nm May be.
- the length range may be 60 to 490 nm.
- the ratio (length / thickness) of the length (nm) to the thickness (nm) can be, for example, about 1 to 200.
- the upper or lower limit of the range of the ratio is, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21. , 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46. , 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71.
- the hydroxyethyl cellulose (HEC) used in the composition of the present disclosure is not particularly limited as long as the effect is not impaired.
- hydroxyethyl cellulose not cross-linked with a cross-linking agent non-cross-linked HEC
- hydroxyethyl cellulose cross-linked with a cross-linking agent cross-linked HEC
- Cross-linked HEC is more preferred.
- cross-linking agent examples include polyvalent aldehyde compounds (preferably dialdehyde compounds) such as glutaraldehyde and glioxal, 2,2-bishydroxymethylbutanol-tris [3- (1-aziridinyl) propionate], 1,8-.
- polyvalent aziridin compounds such as hexamethylene diethylene urea
- polyvalent isocyanate compounds such as tolylene diisocyanate and hexamethylene diisocyanate. Of these, dialdehyde compounds are preferred, and glyoxal is particularly preferred.
- the cross-linking agent may be used alone or in combination of two or more.
- Cross-linking of hydroxyethyl cellulose with a cross-linking agent can be carried out by a known method or a method that can be easily conceived from a known method. For example, it can be carried out by the method described in Japanese Patent Publication No. 58-43402.
- the cross-linked HEC preferably has a cross-linking agent content of, for example, 0.05% by mass or more, and more preferably about 0.05 to 2% by mass.
- the upper or lower limit of the cross-linking agent content ratio range is, for example, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.11, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, 0.18, 0.19, 0.2, 0.21, 0.22, 0.23, 0.24, 0.25, 0.
- the cross-linking agent content ratio range may be 0.1 to 1% by mass. In particular, 0.35% by mass or more is preferable.
- Cross-linking of hydroxyethyl cellulose with a cross-linking agent can be carried out by a known method or a method that can be easily conceived from a known method. For example, it can be carried out by the method described in Japanese Patent Publication No. 58-43402.
- the HEC (including non-crosslinked HEC and crosslinked HEC) preferably has a viscosity of a 1.33% by mass (w / w%) aqueous solution at 25 ° C. of 4000 mPa ⁇ s or more, and more preferably 4000 to 18000 mPa ⁇ s. preferable.
- the upper or lower limit of the viscosity range is, for example, 4100, 4200, 4300, 4400, 4500, 4600, 4700, 4800, 4900, 5000, 5100, 5200, 5300, 5400, 5500, 5600, 5700, 5800, 5900, 6000.
- the viscosity range may be 4100 to 17900 mPa ⁇ s.
- the HEC (including the non-crosslinked HEC and the crosslinked HEC) is not particularly limited, but the molecular weight is preferably, for example, about 1800000 to 430000.
- the upper or lower limit of the molecular weight range is, for example, 19000000, 2000000, 210000, 2200, 230000, 2400000, 25, 260000, 2700, 280000, 2900, 3000, 3100, 3200, 3300, 3400, 3500, 3600, 3700, 380000, It may be 3900000, 4000, 410000, or 4200000.
- the molecular weight range may be 1900000 to 4200000.
- the molecular weight is a mass average molecular weight obtained by gel permeation chromatography (GPC) and converted into polyethylene oxide.
- GPC gel permeation chromatography
- Examples of the column for measuring the mass average molecular weight in terms of polyethylene glycol by GPC include Shodex OHpak SB-807HQ, Shodex OHpak SB-806HQ, Shodex OHpak SB-804HQ and the like. Detailed GPC measurement conditions are shown below.
- HEC is a compound in which the OH group of cellulose is OR (R indicates H or CH 2 CH 2 OH), and is contained in the composition of the present disclosure.
- HEC including non-crosslinked HEC and crosslinked HEC
- a group other than H or CH 2 CH 2 OH may be present as R of the OR, but it is preferable that no hydrophobic group is present as R.
- R an alkyl group, particularly a linear chain having 6 to 20 carbon atoms (6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20) or Those having a branched chain alkyl group (more specifically, for example, a cetyl group) may be used, but it is preferable not to use them.
- the composition of the present disclosure contains water as a solvent. Further, a solvent other than water may be further contained as long as the effect of the composition of the present disclosure is not impaired.
- the solvent other than water include water-soluble solvents, and for example, water-soluble organic solvents are preferable.
- the water-soluble organic solvent include monohydric or divalent alkyl alcohols having 1 to 6 carbon atoms (1, 2, 3, 4, 5, or 6), and more specifically, for example. Examples thereof include ethanol and butylene glycol.
- the value of the storage elastic modulus (G') is larger than the value of the loss elastic modulus (G'') (that is, the storage elastic modulus G'> the loss elastic modulus G'').
- the one is preferable.
- the composition of the present disclosure preferably has a loss tangent (tan ⁇ ) of less than 1 (that is, tan ⁇ ⁇ 1).
- the loss tangent (tan ⁇ ) is the ratio (G ′′ / G ′) of the storage elastic modulus (G ′) and the loss elastic modulus (G ′′), and is used as one of the indexes of the viscoelastic property.
- the larger the value of the loss tangent the smaller the elastic modulus.
- the loss tangent is used as an index of sol and gel, and usually tan ⁇ > 1 is sol and tan ⁇ ⁇ 1 is gel.
- the values of the storage elastic modulus G ′ and the loss elastic modulus G ′′ can be measured at 25 ° C. using a viscoelasticity measuring device (leometer). More specifically, after confirming the linear region by measuring the strain dispersion at 1 Hz, an appropriate distortion is selected within the range of the linear region, and the frequency dispersion at 25 ° C. (frequency: 0.1 rad / s to 100 rad / s). And observe the magnitude relationship between G'and G''.
- the storage elastic modulus G'and the loss elastic modulus G'' obtained by frequency dispersion measurement have a magnitude relationship of the storage elastic modulus G in the entire range of frequency: 0.1 rad / s to 100 rad / s. '> Loss elastic modulus G'' is preferable.
- composition of the present disclosure has a viscosity at 25 ° C. of 10,000 mPa ⁇ s or more, preferably 10,000 to 20,000 mPa ⁇ s.
- the upper or lower limit of the viscosity range is, for example, 10100, 10200, 10300, 10400, 10500, 10600, 10700, 10800, 10900, 11000, 11100, 11200, 11300, 11400, 11500, 11600, 11700, 11800, 11900, 12000.
- the viscosity range may be 8100 to 19,900 mPa ⁇ s.
- the viscosity is a value measured at 25 ° C. using a rotary viscometer manufactured by BrookField (model number: DVE, spindle: LV) at a rotation speed of 20 rpm.
- the spindle used for measurement is spindle LV-1 when it is less than 200 mPa ⁇ s, spindle LV-2 when it is 200 mPa ⁇ s or more and less than 1000 mPa ⁇ s, and 1000 mPa ⁇ s or more and less than 4000 mPa ⁇ s.
- a water-soluble salt is preferable as the salt.
- the water-soluble salt include water-soluble inorganic salts and organic salts.
- the inorganic salt include hydrochloride, hydrobromide, sulfate, nitrate, phosphate, phosphate ester salt and the like
- examples of the organic salt include acetate, 2,2-dichloroacetate and the like.
- these salts include sodium salt, potassium salt, lithium salt, ammonium salt, calcium salt, magnesium salt, iron salt, zinc salt, copper salt, manganese salt, aluminum salt and the like. .. Among them, hydrochloride, phosphate, phosphate ester salt, acetate, ascorbate, ascorbic acid phosphate, asparagate, carbonate, citrate, fumarate, lactate, maleate, apple Acid salts, malonates, oxalates and the like are preferable, and these sodium salts, potassium salts, ammonium salts, calcium salts, magnesium salts and the like are more preferable.
- examples of the salt include sodium chloride, sodium ascorbate, magnesium ascorbate, sodium ascorbate, and the like.
- sodium chloride, ascorbic acid salt, ascorbic acid derivative salt (for example, ascorbic acid phosphate) and the like are preferable.
- the salt can be used alone or in combination of two or more.
- CNC is preferably about 0.05 to 1 part by mass.
- the upper or lower limit of the range is, for example, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, It may be 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, or 0.95.
- the range may be 0.1 to 0.8.
- the CNC content in the composition of the present disclosure is not particularly limited as long as the effect is not impaired, and examples thereof include about 0.1 to 5% by mass.
- the upper or lower limit of the range is, for example, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2.
- the HEC (including non-crosslinked HEC and crosslinked HEC) content in the composition of the present disclosure is not particularly limited as long as the effect is not impaired, but is, for example, about 0.1 to 5% by mass. Can be mentioned.
- the upper or lower limit of the range is, for example, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2.
- the salt content in the salt-containing composition of the present disclosure is preferably 0.1% by mass or more, more preferably about 0.1 to 10% by mass.
- the upper or lower limit of the range (0.1 to 10% by mass) is, for example, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 2.1, 2.2, 2. 3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3, 3.1, 3.2, 3.3, 3.4, 3.5, 3. 6, 3.7, 3.8, 3.9, 4, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.
- composition of the present disclosure preferably has a transmittance of 10% or more.
- the transmittance is, for example, 11% or more, 12% or more, 13% or more, 14% or more, 15% or more, 16% or more, 17% or more, 18% or more, 19% or more, 20% or more, 21% or more.
- the upper limit of the transmittance is not particularly limited, but for example, 95% or less can be exemplified.
- the transmittance is specifically a value obtained by measuring the transmittance (% T) of UV (425 nm) (calibrated so that the distilled water has a transmittance of 100%).
- the high transmittance of the composition means that the transparency of the composition is high. It is not always required that the composition be transparent, but it is preferable because it is in high demand especially in the cosmetics field.
- Such excellent transmittance can be achieved when the HEC used is a crosslinked HEC and the crosslinker content ratio of the crosslinked HEC is relatively high.
- the ratio is preferably 0.35% by mass or more, more preferably about 0.35 to 2% by mass.
- composition of the present disclosure may contain components other than CNC, HEC (including non-crosslinked HEC and crosslinked HEC), salt, and water as long as the effect is not impaired.
- HEC including non-crosslinked HEC and crosslinked HEC
- salt including salt, and water as long as the effect is not impaired.
- examples of such an ingredient include simple substances and ingredients known in the fields of pharmaceuticals, cosmetics, and foods.
- the composition of the present disclosure can be prepared, for example, by mixing CNC and HEC (including non-crosslinked HEC and crosslinked HEC) and then mixing the mixture with water. Thus, it is desirable to mix CNC and HEC before adding to water.
- the composition of the present disclosure can have the above-mentioned excellent viscosity not only when it does not contain a salt but also when it contains a salt.
- both CNC and HEC used for mixing before being added to water are powders. Further, the mixture of CNC and HEC to be added to water is preferably a powder.
- the salt-containing composition of the present disclosure can be prepared, for example, by adding a salt to a viscous composition prepared by adding a mixture of CNC and HEC to water and mixing them as necessary.
- a viscous composition prepared by adding a mixture of CNC and HEC to water and mixing them as necessary is useful as a viscous composition for salt addition.
- composition of the present disclosure has excellent viscosity and viscoelasticity, it is useful in technical fields in which products required to have such properties exist, for example, in the fields of pharmaceuticals, cosmetics, and foods. That is, the composition of the present disclosure can be preferably used, for example, as a pharmaceutical composition, a cosmetic composition, a food composition, or the like.
- Measurement conditions Leometer: TA Instrument AR-2000ex Plate: 60 mm, 1 ° cone plate Measurement temperature: 25 ° C Distortion: 0.1 to 10% (selected within the range of the linear region obtained in the distortion dispersion measurement at 1 Hz) Frequency: 0.1 rad / s to 100 rad / s [Viscosity measurement] The viscosity of each viscous composition was measured at 25 ° C. using a rotary viscometer (model number: DVE, spindle: LV) manufactured by BrookField at a rotation speed of 20 rpm.
- the spindle used for measurement is spindle LV-1 when it is less than 200 mPa ⁇ s, spindle LV-2 when it is 200 mPa ⁇ s or more and less than 1000 mPa ⁇ s, and 1000 mPa ⁇ s or more and less than 4000 mPa ⁇ s.
- the transmittance of each viscous composition was measured as follows.
- a spectrophotometer (model number: UV-1850) manufactured by Shimadzu Corporation was used for the measurement. First, the sample was placed in a cell for UV measurement (optical path length 1 cm), and defoamed by a centrifuge at 2,000 rpm for 5 minutes. If the defoaming was not completed, the same operation was performed with a centrifuge, and it was confirmed that the bubbles were completely removed from the upper part of the sample. Then, the sample was set in a spectrophotometer, and the transmittance was measured with the measurement wavelength set to 425 nm. The distilled water was calibrated so as to have a transmittance of 100%. [Stability] It was visually confirmed whether the components contained in each viscous composition did not separate.
- HEC CF-Y
- HEC SZ-25F
- AQUAPEC HV-505E is a carbomer
- AQUAPEC HV-501ER is a (Acrylate / alkyl acrylate (C10-30)) cross polymer.
- the HECs used were all cross-linked HECs cross-linked with a cross-linking agent (glyoxal), and the content of the cross-linking agent in each cross-linked HEC was 0.55% by mass for HEC (CF-Y) and HEC (SZ-25F). Is 0.29% by mass.
- a powder of crystal nanocellulose and a powder of a water-soluble polymer (HEC) are mixed, and the mixed powder is stirred and mixed with ion-exchanged water to dissolve it, and a water-soluble salt (specifically, a water-soluble salt (specifically)) is added thereto.
- a water-soluble salt specifically, a water-soluble salt (specifically)
- sodium chloride or L-ascorbic acid phosphate magnesium was mixed to prepare a viscous composition. More specifically, 0.33 g of cellulose nanocrystals and 1 g of hydroxyethyl cellulose are mixed in a powder state, the mixed powder is put into 93.67 g of water, and the mixture is stirred with a 4-paddle stirring blade at 500 rpm for 4 hours to gel.
- the viscous compositions of Comparative Examples 3 to 4 were prepared by dispersing crystal nanocellulose in ion-exchanged water, dissolving a water-soluble salt in the viscous composition, and finally dissolving a water-soluble polymer.
- Examples 1 to 4 the viscoelasticity, viscosity, and transmittance of the composition before mixing the water-soluble salt were also measured.
- the viscous compositions of Comparative Examples 1 and 2 were prepared by stirring and mixing a water-soluble polymer (AQUAPEC) in ion-exchanged water, dispersing the mixture, neutralizing the pH to 7 with NaOH, and further mixing and mixing a water-soluble salt.
- AQUAPEC water-soluble polymer
- Comparative Examples 1 and 2 the viscoelasticity and viscosity of the composition before mixing the water-soluble salt were also measured. The results are also shown in Table 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Manufacturing & Machinery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022554079A JPWO2022071463A1 (enrdf_load_stackoverflow) | 2020-10-02 | 2021-09-30 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020167876 | 2020-10-02 | ||
JP2020-167876 | 2020-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022071463A1 true WO2022071463A1 (ja) | 2022-04-07 |
Family
ID=80951644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/036041 WO2022071463A1 (ja) | 2020-10-02 | 2021-09-30 | 粘性組成物 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2022071463A1 (enrdf_load_stackoverflow) |
WO (1) | WO2022071463A1 (enrdf_load_stackoverflow) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023013537A1 (ja) * | 2021-08-06 | 2023-02-09 | 住友精化株式会社 | 粘性組成物 |
WO2023013535A1 (ja) * | 2021-08-06 | 2023-02-09 | 住友精化株式会社 | 粘性組成物 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5843402B2 (ja) * | 1977-02-18 | 1983-09-27 | フジケミカル株式会社 | ヒドロキシエチルセルロ−スの製法 |
JP2012531478A (ja) * | 2009-06-30 | 2012-12-10 | アルバータ イノベイツ−テクノロジー フューチャーズ | ナノ結晶セルロースを用いて処方した航空機用防氷液 |
JP2015527451A (ja) * | 2012-07-31 | 2015-09-17 | ハーキュリーズ・インコーポレーテッド | 安定化多相水性組成物 |
WO2018061890A1 (ja) * | 2016-09-29 | 2018-04-05 | 住友精化株式会社 | 水溶性ヒドロキシエチルセルロースの製造方法 |
JP2018104616A (ja) * | 2016-12-28 | 2018-07-05 | 株式会社パイロットコーポレーション | 筆記具用水性インキ組成物およびそれを用いた筆記具 |
JP2019520393A (ja) * | 2016-07-08 | 2019-07-18 | アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag | 医薬組成物 |
CN110183698A (zh) * | 2019-06-28 | 2019-08-30 | 陕西科技大学 | 一种hec/cnc/聚多异氰酸酯复合膜及其制备方法和应用 |
-
2021
- 2021-09-30 JP JP2022554079A patent/JPWO2022071463A1/ja active Pending
- 2021-09-30 WO PCT/JP2021/036041 patent/WO2022071463A1/ja active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5843402B2 (ja) * | 1977-02-18 | 1983-09-27 | フジケミカル株式会社 | ヒドロキシエチルセルロ−スの製法 |
JP2012531478A (ja) * | 2009-06-30 | 2012-12-10 | アルバータ イノベイツ−テクノロジー フューチャーズ | ナノ結晶セルロースを用いて処方した航空機用防氷液 |
JP2015527451A (ja) * | 2012-07-31 | 2015-09-17 | ハーキュリーズ・インコーポレーテッド | 安定化多相水性組成物 |
JP2019520393A (ja) * | 2016-07-08 | 2019-07-18 | アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag | 医薬組成物 |
WO2018061890A1 (ja) * | 2016-09-29 | 2018-04-05 | 住友精化株式会社 | 水溶性ヒドロキシエチルセルロースの製造方法 |
JP2018104616A (ja) * | 2016-12-28 | 2018-07-05 | 株式会社パイロットコーポレーション | 筆記具用水性インキ組成物およびそれを用いた筆記具 |
CN110183698A (zh) * | 2019-06-28 | 2019-08-30 | 陕西科技大学 | 一种hec/cnc/聚多异氰酸酯复合膜及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
LENFANT GILLES, MARIE-CLAUDE HEUZEY, THEO G.M. VAN DE VEN PIERRE J. CARREAU: "GELATION OF CRYSTALLINE NANOCELLULOSE IN THE PRESENCE OF HYDROXYETHYL CELLULOSE", THE CANADIAN JOURNAL OF CHEMICAL ENGINEERING, vol. 95, 21 April 2017 (2017-04-21), pages 1891 - 1900, XP055918199 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023013537A1 (ja) * | 2021-08-06 | 2023-02-09 | 住友精化株式会社 | 粘性組成物 |
WO2023013535A1 (ja) * | 2021-08-06 | 2023-02-09 | 住友精化株式会社 | 粘性組成物 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2022071463A1 (enrdf_load_stackoverflow) | 2022-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Fabrication and characterization of chitin nanofibers through esterification and ultrasound treatment | |
WO2022071474A1 (ja) | 粘性組成物 | |
Meesorn et al. | A simple and versatile strategy to improve the mechanical properties of polymer nanocomposites with cellulose nanocrystals | |
CN107532377B (zh) | 纳米原纤纤维素产品 | |
EP1078008B1 (en) | Microfibrillar cellulose derivatized to comprise anionic charges | |
Jin et al. | Comparison of curdlan and its carboxymethylated derivative by means of Rheology, DSC, and AFM | |
Zhang et al. | Physicochemical properties, antioxidant and antibacterial activities of dialdehyde microcrystalline cellulose | |
Chen et al. | Morphological changes of sterically stabilized nanocrystalline cellulose after periodate oxidation | |
CN105492689B (zh) | 改性纳米原纤纤维素组合物的方法 | |
US6610810B2 (en) | Biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere | |
WO2022071473A1 (ja) | 粘性組成物 | |
Andrade et al. | Stable microfluidized bacterial cellulose suspension | |
WO2022071463A1 (ja) | 粘性組成物 | |
Martins et al. | Dry Bacterial Cellulose and Carboxymethyl Cellulose formulations with interfacial-active performance: processing conditions and redispersion | |
WO2022071461A1 (ja) | 粘性組成物 | |
Ono et al. | Structures, molar mass distributions, and morphologies of TEMPO-oxidized bacterial cellulose fibrils | |
Wang et al. | Ultrasonication-based preparation of raw chitin nanofiber and evaluation of its reinforcement effect on chitosan film for functionalization with curcumin | |
JP2023539608A (ja) | ナノセルロースの調製のための効率的なグリーンプロセス、新規な変性ナノセルロース及びその用途 | |
WO2023013533A1 (ja) | 粘性組成物 | |
CN104640882A (zh) | 用于制备适合分散在水性介质中的原纤化纤维素粉末的方法 | |
Lima et al. | Functionalized Cellulose Nanofibrils Obtained from Cellulose Oxypropylated | |
WO2023013535A1 (ja) | 粘性組成物 | |
Khavpachev et al. | Solvent-Free Interaction of Gallic Acid with Chitosan via Reactive Extrusion | |
US20240384009A1 (en) | Method for producing surface modified nanocellulose material | |
EP3991761A1 (en) | Dermal filler composition comprising modified cellulose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21875759 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022554079 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21875759 Country of ref document: EP Kind code of ref document: A1 |